Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization and treatment of persistent hepatocellular secretory failure.

Liver international : official journal of the International Association for the Study of the Liver - 1 Apr 2015

van Dijk Remco, Kremer Andreas E, Smit Wouter, van den Elzen Bram, van Gulik Thomas, Gouma Dirk, Lameris Johan S, Bikker Hennie, Enemuo Valentine, Stokkers Pieter C F, Feist Mark, Bosma Piter, Jansen Peter L M, Beuers Ulrich

Abstract excerpt

BACKGROUND & AIMS: Hepatocellular secretory failure induced by drugs, toxins or transient biliary obstruction may sometimes persist for months after removal of the initiating factor and may then be fatal without liver transplantation. We characterized patients with severe persistent hepatocellula...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 11
Share to Bilirubin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholestasis

Share to HT29 Cells

Share to Liver Failure

Share to Multidrug Resistance-Associated Protein 2

Share to Pregnane X Receptor

Share to Receptors, Steroid

Source

Identifiers

PMID: 24905729
DOI: 10.1111/liv.12603

Genes

ABCB11

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24905729-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization and treatment of persistent hepatocellular secretory failure.PMID 24905729Read ↗

Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.Semantic proximity Read ↗

Liver disease associated with canalicular transport defects: current and future therapies.Semantic proximity Read ↗

Rifampicin Induces Gene, Protein, and Activity of P-Glycoprotein (ABCB1) in Human Precision-Cut Intestinal SlicesSemantic proximity Read ↗

Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.Semantic proximity Read ↗

Transcriptional regulation of hepatobiliary transport systems in health and disease: Implications for a rationale approach to the treatment of intrahepatic cholestasisSemantic proximity Read ↗

Role of pregnane X-receptor in regulating bacterial translocation in chronic liver diseasesSemantic proximity Read ↗

Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human HepatocytesSemantic proximity Read ↗

Hepatic secretion of conjugated drugs and endogenous substances.Semantic proximity Read ↗

Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.Semantic proximity Read ↗

Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase–signaling pathwaySemantic proximity Read ↗

A Drug Regimen for Progressive Familial Cholestasis Type 2.Semantic proximity Read ↗

GLUCURONIDATION: THE LAST DEFENSIVE LINE AGAINST BILE ACID TOXICITY DURING CHOLESTASIS.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.